Linked Life Data

18637467

Source:http://linkedlifedata.com/resource/pubmed/id/18637467

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2008-7-21
pubmed:abstractText
The clinical outcome of LT has improved significantly with refinements in surgical skill and immunosuppressive agents. Over the past decade, nationally most LT centers have improved their standard care in LT. As a result, short-term survival after LT has increased remarkably. However, recurrence of original liver disease, chronic rejection, and the adverse effect of immunosuppressive agents still impose significant limitations on long-term survival. Here at the MTI, it is our mission to continue technical innovation, improve the management of hepatitis C patients, search for better immunosuppressive protocols, and work towards achieving tolerance after LT to improve the long-term outcome.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0890-9016
pubmed:author
pubmed:issnType
Print
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
155-64
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Liver transplantation at the Miami Transplant Institute: a 14-year single-center experience.
pubmed:affiliation
Miami Transplant Institute, University of Miami, Miami, USA.
pubmed:publicationType
Journal Article, Review